REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,364 | -79.3% | 76 | -76.9% | 0.00% | – |
| Q2 2023 | $6,577 | +657600.0% | 329 | +532.7% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 52 | -70.1% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 174 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -14.3% | 174 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 174 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | +16.7% | 174 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 174 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +300.0% | 174 | +117.5% | 0.00% | – |
| Q3 2020 | $2,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |